Results 71 to 80 of about 21,136 (195)

Kidney injury in patients with heart failure‐related cardiogenic shock: Results from an international, multicentre cohort study

open access: yesEuropean Journal of Heart Failure, Volume 27, Issue 11, Page 2397-2409, November 2025.
Kidney injury in heart failure‐related cardiogenic shock. AKI, acute kidney injury; CI, confidence interval; eCPR, extracorporeal cardiopulmonary resuscitation; eGFR, estimated glomerular filtration rate; HR, hazard ratio; OR, odds ratio; VA‐ECMO, veno‐arterial extracorporeal membrane oxygenation.
Jonas Sundermeyer   +41 more
wiley   +1 more source

STREPTOKINASE EFFICACY IN MYOCARDIAL INFARCTION MANAGEMENT: IS IT RELATED TO SERUM ANTISTREPTOKINASE ANTIBODY TITER

open access: yesJournal of Research in Medical Sciences, 2000
Introduction. Antistreptokinase antibodies in sera of individuals with previous streptococcal infection might theoretically influence the thrombolytic activity of streptokinase. Streptokinase as the only thrombolytic drug is used in MI management in Iran.
H SHEMIRANI   +3 more
doaj  

Imaging guided streptokinase injected through small bore pigtail tail catheter in management of complicated empyema in pediatrics

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine, 2017
Purpose: This study was done targeting the role of streptokinase injected through pigtail catheter in treatment of pleural empyema in pediatric. Subjects and methods: 15 patients were involved in this study of age ranged from 5 months to 15 years were ...
Sherif El-Sayed Mahmoud Hegab   +3 more
doaj   +1 more source

Thrombolysis and interventional cardiology; experiences from the 80's [PDF]

open access: yes, 1992
In October 1978 I assumed the position of cardiologist at the Catharina Hospital in Eindhoven at the time when the cardiothoracic surgery programm began in this hospital.
Bonnier, J.J.R.M. (Hans)
core  

Does aspirin detract from the benefits of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction? Probably! [PDF]

open access: yes, 2017
No abstract ...
Aspirin Myocardial Infarction Study Research Group   +23 more
core   +1 more source

Alveolar Hemorrhage Following Thrombolytic Therapy for Acute Myocardial Infarction: Two Case Reports and Literature Review

open access: yesOpen Access Emergency Medicine, 2021
Imtinene Ben Mrad,1 Melek Ben Mrad,2 Zeineb Oumaya,1 Ihsen Zairi,1 Boutheina Besbes,1 Khalil Ouaghlani,1 Sofien kamoun,1 Sobhi Mleyhi,2 Rim Miri,2 khadija Mzoughi,1 Sondos Kraiem1 1Cardiology Department, Habib Thameur Hospital, Tunis, Tunisia ...
Ben Mrad I   +10 more
doaj  

Impact of Śodhana (Ayurvedic purification process) on thrombolytic effect of Semecarpus anacardium Linn. f. Nut

open access: yesAncient Science of Life, 2017
Aims and Objectives: In vitro evaluation and comparison of thrombolytic activity of raw and purified bhallātaka (Semecarpus anacardium Linn.f.) nuts by means of % of clot lysis.
Dattatray D Sarvade   +2 more
doaj   +1 more source

Fibrinolytic Activity of Recombinant Mutant Streptokinase

open access: yesNovelty in Biomedicine, 2015
Background: Streptokinase is a bacterial protein produced by different beta hemolytic streptococci and widely used in thrombolytic treatment. The main disadvantage of using streptokinase is antibody formation which causes allergic reaction to neutralize ...
Mahboobeh Mobarrez   +3 more
doaj  

Identification of Human Blood on the Basis of the Fibrin Plate Method [PDF]

open access: yes, 1962
The method of identifying human blood is studied from the standpoint of the fibrinolytic enzyme system by means of the "fibrin plate method" and the following results are obtained: 1) "Fibrin plate method" is, in the point of its ...
Kumano, Osamu
core   +1 more source

Evaluation of Streptokinase Production Potential by Group C Streptococcal Strain H46A in Batch Culture and Bactericidal Effect of Hexyl Resorcinol

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2009
BACKGROUND AND OBJECTIVE: Streptokinase (SK) is a microbial plasminogen-activator that is used in the treatments, especially at Acute ischemic stroke, declotting of dialysis shunts and inflammatory antibiotic-resistant prostatitis.
MR Nejadmoghaddam,   +2 more
doaj  

Home - About - Disclaimer - Privacy